losartan has been researched along with Endocardial Fibroelastosis in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Endocardial Fibroelastosis: A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (CARDIOMYOPATHY, RESTRICTIVE). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (HEART DEFECTS CONGENITAL;) INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vorisek, C | 1 |
| Weixler, V | 1 |
| Dominguez, M | 1 |
| Axt-Fliedner, R | 1 |
| Hammer, PE | 1 |
| Lin, RZ | 1 |
| Melero-Martin, JM | 1 |
| Del Nido, PJ | 1 |
| Friehs, I | 1 |
1 other study available for losartan and Endocardial Fibroelastosis
| Article | Year |
|---|---|
Mechanical strain triggers endothelial-to-mesenchymal transition of the endocardium in the immature heart.
Topics: Animals; Bone Morphogenetic Protein 7; Endocardial Fibroelastosis; Endocardium; Endothelial Cells; E | 2022 |